VTS-270

2-hydroxypropyl-beta-cyclodextrin

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for VTS-270, covering 2022-08-30 to 2025-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C [Phase 1, Phase 2]